Last reviewed · How we verify
NCT06373510: ELCAV
Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration of a Non-public Marketed Vaccine in the General Population, Real-life Study
NA trial testing Blood collection in Vaccination Reaction in 10,000 participants. Not yet recruiting.
3 April 2027
Quick facts
| Lead sponsor | CerbaXpert |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 10,000 |
| Start date | 20 June 2024 |
| Primary completion | 3 April 2027 |
| Estimated completion | 3 April 2027 |
Drugs / interventions tested
- Blood collection — full drug profile →
Conditions studied
- Vaccination Reaction — all drugs for Vaccination Reaction →
Sponsor
CerbaXpert
Who can join
Adults 18 to 90, any sex, with Vaccination Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study would make it possible to document more explicitly the evolution of antibody titers at following a non-public vaccination over a large post-vaccination period in the French population . Analysis of real-life data would enhance knowledge of vaccine response kinetics It would be useful to identify possible early declines requiring doses Similarly, by analyzing antibody kinetics by age, sex, and vaccination status, the would be possible to determine whether there are differences in the immune response between these different sub-groups. In addition, it would provide additional information to assess the real impact of these non-public vaccines in public health and guide vaccine policies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06373510
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood collection
Trials testing the same drug.
- NCT07134491 — Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, · recruiting
- NCT07075107 — Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases · NA · not yet recruiting
- NCT06510868 — Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy · recruiting
- NCT06521502 — The APS Phenotyping Study · recruiting
- NCT06432855 — Genetic Determinants of the Antiviral Immune Response in Oceanian Populations · NA · not yet recruiting
Other recruiting trials for Vaccination Reaction
Currently open trials in the same condition.
- NCT06023056 — Hepatitis B Vaccination After Neonatal Surgery · recruiting
Other CerbaXpert trials
Trials by the same sponsor.
- NCT06144333 — Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters C · NA · not yet recruiting
- NCT05983679 — Prevalence of Sexually Transmitted Infections (STIs) and Coinfections in the General Population · not yet recruiting
- NCT06623071 — Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384 · recruiting
- NCT06623058 — Accupower ® HCV Performance Evaluation Quant Kit Bioneer Existation™FA 96/384 · not yet recruiting
- NCT06159257 — Evaluation of the Physiological Stability Variability and Robustness of NIS4 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06373510 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CerbaXpert
- Last refreshed: 18 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06373510.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing